Search
for
Sort by
Research 30 of 1000+
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Use of Finasteride in the Treatment of Men With Androgenetic Alopecia (Male Pattern Hair Loss)
- Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
- Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis
- Enhancing the Growth of Natural Eyelashes: The Mechanism of Bimatoprost-Induced Eyelash Growth
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Efficacy of Placental-Derived Mesenchymal Stem Cell Exosome Therapy in Treating Androgenetic Alopecia: A Clinical Trial Study
- PC-SPES Studies Promising, But Manufacturer Shuts Down
- Progress of Phage Therapy for Acne Vulgaris
- Teriflunomide in multiple sclerosis: an update
- America - A Diversity of Life Styles.
- Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Drug news and therapeutic news
- Discovery and Clinical Development of Dutasteride, a Potent Dual 5α- Reductase Inhibitor
- Prostate cancer update: 2007
- Abstract SS02-02: Chemoprevention: Poised for Success
- 5% Minoxidil topical foam for men: Hair growth in millennials – a post hoc analysis
- Towards a consensus potency assay for mesenchymal stromal cells: a matrix analysis of cell source, donor variability and inflammatory stimuli to refine surrogate markers of immunomodulation
- Dutasteride
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Finasteride
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- New agents for cancer chemoprevention
- Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
- Interventions for preventing the progression of autosomal dominant polycystic kidney disease
- Industry Updates from the Field of Stem Cell Research and Regenerative Medicine in December 2019
- Anthracycline analogs The past, present, and future